Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine

被引：113

作者：

Williamson, Beth ^{[1
]}

Dooley, Kelly E. ^{[2
,3
]}

Zhang, Yuan ^{[1
]}

Back, David J. ^{[1
]}

Owen, Andrew ^{[1
]}

机构：

[1] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England

[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Pharmacol, Baltimore, MD 21205 USA

[3] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2013年 / 57卷 / 12期

关键词：

MULTIDRUG-RESISTANCE PROTEIN-2; CLINICAL PHARMACOKINETICS; TUBERCULOSIS; CELLS; BINDING;

D O I：

10.1128/AAC.01124-13

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Rifampin is a potent inducer of cytochrome P450 (CYP) enzymes and transporters. Drug-drug interactions during tuberculosis treatment are common. Induction by rifapentine and rifabutin is understudied. Rifampin and rifabutin significantly induced CYP3A4 (80-fold and 20-fold, respectively) in primary human hepatocytes. The induction was concentration dependent. Rifapentine induced CYP3A4 in hepatocytes from 3 of 6 donors. Data were also generated for ABCB1, ABCC1, ABCC2, organic anion-transporting polypeptide 1B1 (OATP1B1), and OATP1B3. This work serves as a basis for further study of the extent to which rifamycins induce key metabolism and transporter genes.

引用

页码：6366 / 6369

页数：4

共 50 条

[31] Cytochrome P450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells:: Correlation with alprazolam pharmacokinetics
Gashaw, I
Kirchheiner, J
Goldammer, M
Bauer, S
Seidemann, J
Zoller, K
Mrozikiewicz, PM
Roots, I
Brockmöller, J
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (05) : 448 - 457
[32] Quantitative Cytochrome P450 3A4 Induction Risk Assessment Using Human Hepatocytes Complemented with Pregnane X Receptor Profiles
Ekiciler, Aynur
Chen, Wen Li Kelly
Bo, Yan
Pugliano, Alessandra
Donzelli, Massimiliano
Parrott, Neil
Umehara, Kenichi
DRUG METABOLISM AND DISPOSITION, 2023, 51 (03) : 276 - +
[33] Vinorelbine Inhibits Pregnane X Receptor-Mediated Induction of Cytochrome P450 3A4 Gene Expression in Human Hepatocytes
Chaudhury, Chloe
Abbott, Kodye
Pondugula, Satyanarayana
FASEB JOURNAL, 2016, 30
[34] Structural Dynamics of Cytochrome P450 3A4 in the Presence of Substrates and Cytochrome P450 Reductase
Ducharme, Julie
Sevrioukova, Irina F.
Thibodeaux, Christopher J.
Auclair, Karine
BIOCHEMISTRY, 2021, 60 (28) : 2259 - 2271
[35] Use of primary rat and human hepatocytes for the analysis of cytochrome P450 induction and inhibition
Busquet, F
Simon, S
Czarnota, A
Kling, M
Mueller, SO
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R94 - R94
[36] Screening for cytochrome P450 induction in vitro: The use of primary cultures of human hepatocytes
Wilkinson, DJ
Chadwick, AP
Rosenbrier, L
Malik, N
Bettany, L
Turcan, RG
DRUG METABOLISM REVIEWS, 2003, 35 : 71 - 71
[37] Sensitivity of ivacaftor to drug-drug interactions with rifampin, a cytochrome P450 3A4 inducer
Guimbellot, Jennifer S.
Acosta, Edward P.
Rowe, Steven M.
PEDIATRIC PULMONOLOGY, 2018, 53 (05) : E6 - E8
[38] Guidance for Rifampin and Midazolam Dosing Protocols To Study Intestinal and Hepatic Cytochrome P450 (CYP) 3A4 Induction and De-induction
Asha J Kapetas
Michael J Sorich
A David Rodrigues
Andrew Rowland
The AAPS Journal, 21
[39] Guidance for Rifampin and Midazolam Dosing Protocols To Study Intestinal and Hepatic Cytochrome P450 (CYP) 3A4 Induction and De-induction
Kapetas, Asha J.
Sorich, Michael J.
Rodrigues, A. David
Rowland, Andrew
AAPS JOURNAL, 2019, 21 (05):
[40] Oxcarbazepine accelerates cortisol elimination via cytochrome P450 3A4 induction
Hoegler, W.
Wudy, S. A.
Luef, G.
Hartmann, M. F.
Rauchenzauner, M.
ARCHIVES OF DISEASE IN CHILDHOOD, 2010, 95 (12) : 1065 - 1067

← 1 2 3 4 5 →